Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP718246.RASXKfiq2KGyXF0JtQrHU-8WgfK2r0IJCh-FJb1eBKMMg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP718246.RASXKfiq2KGyXF0JtQrHU-8WgfK2r0IJCh-FJb1eBKMMg130_assertion type Assertion NP718246.RASXKfiq2KGyXF0JtQrHU-8WgfK2r0IJCh-FJb1eBKMMg130_head.
- NP718246.RASXKfiq2KGyXF0JtQrHU-8WgfK2r0IJCh-FJb1eBKMMg130_assertion description "[EGCG inhibited FASN activity, induced apoptosis and caused a marked decrease of human epidermal growth factor receptor 2 (HER2), phosphatidylinositol 3-kinase (PI3K)/AKT and extracellular (signal)-regulated kinase (ERK) 1/2 proteins, in breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718246.RASXKfiq2KGyXF0JtQrHU-8WgfK2r0IJCh-FJb1eBKMMg130_provenance.
- NP718246.RASXKfiq2KGyXF0JtQrHU-8WgfK2r0IJCh-FJb1eBKMMg130_assertion evidence source_evidence_literature NP718246.RASXKfiq2KGyXF0JtQrHU-8WgfK2r0IJCh-FJb1eBKMMg130_provenance.
- NP718246.RASXKfiq2KGyXF0JtQrHU-8WgfK2r0IJCh-FJb1eBKMMg130_assertion SIO_000772 19189648 NP718246.RASXKfiq2KGyXF0JtQrHU-8WgfK2r0IJCh-FJb1eBKMMg130_provenance.
- NP718246.RASXKfiq2KGyXF0JtQrHU-8WgfK2r0IJCh-FJb1eBKMMg130_assertion wasDerivedFrom befree-2016 NP718246.RASXKfiq2KGyXF0JtQrHU-8WgfK2r0IJCh-FJb1eBKMMg130_provenance.
- NP718246.RASXKfiq2KGyXF0JtQrHU-8WgfK2r0IJCh-FJb1eBKMMg130_assertion wasGeneratedBy ECO_0000203 NP718246.RASXKfiq2KGyXF0JtQrHU-8WgfK2r0IJCh-FJb1eBKMMg130_provenance.